Cloverfields Capital Group’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$877K Sell
6,495
-1,674
-20% -$295K 0.27% 78
2026
Q1
$1.47M Buy
8,169
+1
+0% +$171 0.47% 67
2025
Q4
$1.16M Buy
8,168
+1,610
+25% +$183K 0.36% 72
2025
Q3
$532K Sell
6,558
-4,099
-38% -$316K 0.17% 89
2025
Q2
$668K Buy
10,657
+4,025
+61% +$238K 0.2% 94
2025
Q1
$478K Buy
6,632
+78
+1% +$6.35K 0.16% 92
2024
Q4
$564K Buy
6,554
+7
+0.1% +$697 0.18% 92
2024
Q3
$620K Buy
6,547
+3,211
+96% +$285K 0.2% 91
2024
Q2
$319K Buy
3,336
+462
+16% +$54.9K 0.11% 94
2024
Q1
$379K Hold
2,874
0.13% 96
2023
Q4
$415K Buy
+2,874
New +$395K 0.16% 95

Other funds holding ALB

Cloverfields Capital Group's ALB Position: Q2 2026 in Review

Cloverfields Capital Group reduced its Albemarle (ALB) stake by 20% in Q2 2026, selling an estimated $295K and leaving 6,495 shares worth $877K. The position accounts for 0.27% of the portfolio, ranked #78.

Cloverfields Capital Group first reported a position in ALB in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.47M in Q1 2026. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Cloverfields Capital Group held 6,495 shares of Albemarle worth $877K as of Q2 2026.
  • Cloverfields Capital Group sold 1,674 Albemarle shares in Q2 2026, an estimated $295K.
  • Albemarle made up 0.27% of Cloverfields Capital Group's portfolio in Q2 2026, its #78 holding.
  • Cloverfields Capital Group first reported a position in Albemarle in Q4 2023 and has held it in 11 quarters since.
  • Cloverfields Capital Group's Albemarle position peaked at $1.47M in Q1 2026.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Cloverfields Capital Group's 13F filing for Q2 2026, filed 13 Aug 2026.